Lupus and Allied Diseases Association, Inc.
ladaorg.bsky.social
Improving access to care and quality of life by wielding the patient and care partner voice as a catalyst to advance advocacy, education, awareness and research efforts.
👤 Joined on 09 December 2024
112
Followers
162
Following
132
Total Posts
📜 Kullanıcı Geçmişi
- 09 Ara 2024, 09:36
🎉 Bluesky'e katıldı - İlk kullanıcı adı:
@ladaorg.bsky.social
🚫 Blokladığı Kullanıcılar
❤️ Beğendiği Gönderiler
Review in ACR Open Rheumatology explores rheumatic phenotypes of immune checkpoint inhibitor (ICI) toxicity and the current landscape of clinical trials investigating repurposing of DMARDs and biologics for treating ICI-induced systemic inflammatory syndromes doi.org/10.1002/acr2...
Show Post
That’s a wrap! Two days of dynamic data and lively discussions around Accelerating Product Development for Pediatric Systemic Lupus Erythematosus (SLE). We are hopeful that this can lead to advancement and approval of more treatments for youth with Lupus.💜 #LupusChat #LADAOrg @ladaorg.bsky.social
Show PostDr. Hermine Brunner shared Lessons Learned from Conducting Clinical Trials in Pediatric SLE. Dr. Brunner discussed how trials have been delayed due to restrictive eligibility criteria and recruitment/enrollment difficulty. #LupusChat #LADAorg @ladaorg.bsky.social
Show PostPatients and Care Partners, McKenna Bowes, Chloe Raymond, Nis Cooper, Elizabeth SantaCruz, and Miah Andrade for the final patient panel of the day Patient/Family Panel: Risk Tolerance and Enrollment in Clinical Trials moderated by Dr. Stacy Ardoin #LupusChat #LADAorg @ladaorg.bsky.social
Show Post
Low dose ASA (81mg or 325mg) increase gout attacks by 81% (RR 1.81). Effect nullified by allopurinol use. For more gout content, follow our Gout: More than Flares campaign at buff.ly/ysjKsTy,
Show Post